Description

Antibodies are proteins produced by the immune system in response to the introduction of a foreign body (known as an antigen). Antibodies have a variety of uses – in basic research, diagnostic tests and theraputics. As a cornerstone of the body’s immune response, antibodies can provide significant data to support scientists’ research. According to StrategyHelix, the global research antibodies market is expected to increase by US$ 1,364.3 million during 2022-2028, expanding at a CAGR of 5.6% during the forecast period.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for research antibodies. The global research antibodies market is segmented on the basis of product, clonality, major reactivities, technology, end user, and region. Based on product, the global research antibodies market is categorized into primary antibodies, secondary antibodies. The primary antibodies segment held the largest share of the global research antibodies market in 2021 and is anticipated to hold its share during the forecast period. On the basis of clonality, the global research antibodies market has been segmented into monoclonal antibodies, polyclonal antibodies. Globally, the polyclonal antibodies segment made up the largest share of the research antibodies market. By major reactivities, the global research antibodies market has been segmented into human, mouse, rat. The human segment was the largest contributor to the global research antibodies market in 2021. Based upon technology, the global research antibodies market is categorized into enzyme-linked immunosorbent assay (ELISA), flow cytometry, immunofluorescent staining, immunohistochemistry, western blotting. On the basis of end user, the global research antibodies market has been segmented into pharma & biotech companies, academic and research institutions. Geographically, the global research antibodies market is segmented into Asia Pacific, Europe, North America, Rest of the World (RoW).

The global research antibodies market is highly competitive. The prominent players operating in the global research antibodies market include Abcam plc, Agilent Technologies Inc., Beckman Coulter Inc., Becton Dickinson and Company, Bio-Rad AbD Serotec GmbH, Bio-Techne Corporation, Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, Merck KGaA, Santa Cruz Biotechnology Inc., Thermo Fisher Scientific Inc.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the research antibodies market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Product: primary antibodies, secondary antibodies
Clonality: monoclonal antibodies, polyclonal antibodies
Major reactivities: human, mouse, rat
Technology: enzyme-linked immunosorbent assay (ELISA), flow cytometry, immunofluorescent staining, immunohistochemistry, western blotting
End user: pharma & biotech companies, academic and research institutions
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2018 to 2028

Key Benefits for Stakeholders

– Get a comprehensive picture of the global research antibodies market
– Identify regional strategies and strategic priorities on the basis of local data
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Research antibodies market overview
Part 3. Market breakdown by product
– Primary antibodies
– Secondary antibodies
Part 4. Market breakdown by clonality
– Monoclonal antibodies
– Polyclonal antibodies
Part 5. Market breakdown by major reactivities
– Human
– Mouse
– Rat
Part 6. Market breakdown by technology
– Enzyme-linked immunosorbent assay (ELISA)
– Flow cytometry
– Immunofluorescent staining
– Immunohistochemistry
– Western blotting
Part 7. Market breakdown by end user
– Pharma & biotech companies
– Academic and research institutions
Part 8. Market breakdown by region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
Part 9. Key companies
– Abcam plc
– Agilent Technologies, Inc.
– Beckman Coulter Inc.
– Becton, Dickinson and Company
– Bio-Rad AbD Serotec GmbH
– Bio-Techne Corporation
– Cell Signaling Technology, Inc.
– F. Hoffmann-La Roche AG
– Merck KGaA
– Santa Cruz Biotechnology, Inc.
– Thermo Fisher Scientific Inc.
About StrategyHelix
Disclaimer